These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 27793221)

  • 1. Cognitive Function and the Microbiome.
    Gareau MG
    Int Rev Neurobiol; 2016; 131():227-246. PubMed ID: 27793221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intestinal microbiota in health and disease: role of bifidobacteria in gut homeostasis.
    Tojo R; Suárez A; Clemente MG; de los Reyes-Gavilán CG; Margolles A; Gueimonde M; Ruas-Madiedo P
    World J Gastroenterol; 2014 Nov; 20(41):15163-76. PubMed ID: 25386066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microbiota-gut-brain axis and cognitive function.
    Gareau MG
    Adv Exp Med Biol; 2014; 817():357-71. PubMed ID: 24997042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From gut dysbiosis to altered brain function and mental illness: mechanisms and pathways.
    Rogers GB; Keating DJ; Young RL; Wong ML; Licinio J; Wesselingh S
    Mol Psychiatry; 2016 Jun; 21(6):738-48. PubMed ID: 27090305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of Gut Microbiota-Brain Axis by Probiotics, Prebiotics, and Diet.
    Liu X; Cao S; Zhang X
    J Agric Food Chem; 2015 Sep; 63(36):7885-95. PubMed ID: 26306709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut/brain axis and the microbiota.
    Mayer EA; Tillisch K; Gupta A
    J Clin Invest; 2015 Mar; 125(3):926-38. PubMed ID: 25689247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut-to-Brain Axis in Autism Spectrum Disorders: Central Role for the Microbiome.
    Kraneveld AD; Szklany K; de Theije CG; Garssen J
    Int Rev Neurobiol; 2016; 131():263-287. PubMed ID: 27793223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Physiological patterns of intestinal microbiota. The role of dysbacteriosis in obesity, insulin resistance, diabetes and metabolic syndrome].
    Halmos T; Suba I
    Orv Hetil; 2016 Jan; 157(1):13-22. PubMed ID: 26708682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treating irritable bowel syndrome with probiotics: the evidence.
    Parkes GC; Sanderson JD; Whelan K
    Proc Nutr Soc; 2010 May; 69(2):187-94. PubMed ID: 20236566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of microbiota on brain and behavior: mechanisms & therapeutic potential.
    Borre YE; Moloney RD; Clarke G; Dinan TG; Cryan JF
    Adv Exp Med Biol; 2014; 817():373-403. PubMed ID: 24997043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut microbial metabolism and colon cancer: can manipulations of the microbiota be useful in the management of gastrointestinal health?
    Belcheva A; Irrazabal T; Martin A
    Bioessays; 2015 Apr; 37(4):403-12. PubMed ID: 25601287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microbiome Disturbances and Autism Spectrum Disorders.
    Rosenfeld CS
    Drug Metab Dispos; 2015 Oct; 43(10):1557-71. PubMed ID: 25852213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The gut microbiome and the brain.
    Galland L
    J Med Food; 2014 Dec; 17(12):1261-72. PubMed ID: 25402818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Probiotics in the management of irritable bowel syndrome and inflammatory bowel disease.
    Whelan K; Quigley EM
    Curr Opin Gastroenterol; 2013 Mar; 29(2):184-9. PubMed ID: 23286925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Challenges set by the microbiota].
    Debré P
    Biol Aujourdhui; 2017; 211(1):19-28. PubMed ID: 28682224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microbiota Transfer Therapy alters gut ecosystem and improves gastrointestinal and autism symptoms: an open-label study.
    Kang DW; Adams JB; Gregory AC; Borody T; Chittick L; Fasano A; Khoruts A; Geis E; Maldonado J; McDonough-Means S; Pollard EL; Roux S; Sadowsky MJ; Lipson KS; Sullivan MB; Caporaso JG; Krajmalnik-Brown R
    Microbiome; 2017 Jan; 5(1):10. PubMed ID: 28122648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Irritable Bowel Syndrome; gut microbiota and probiotic therapy].
    Tojo González R; Suarez Gonzalez A; Rúas Madiedo P; Mancebo Mata A; Pipa Muñiz M; Barreiro Alonso E; Roman Llorente FJ; Moro Villar MC; Arce González MM; Villegas Diaz MF; Mosquera Sierra E; Ruiz Ruiz M
    Nutr Hosp; 2015 Feb; 31 Suppl 1():83-8. PubMed ID: 25659060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prebiotic effects: metabolic and health benefits.
    Roberfroid M; Gibson GR; Hoyles L; McCartney AL; Rastall R; Rowland I; Wolvers D; Watzl B; Szajewska H; Stahl B; Guarner F; Respondek F; Whelan K; Coxam V; Davicco MJ; Léotoing L; Wittrant Y; Delzenne NM; Cani PD; Neyrinck AM; Meheust A
    Br J Nutr; 2010 Aug; 104 Suppl 2():S1-63. PubMed ID: 20920376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the intestinal microbiota and its interaction with probiotics and health impacts.
    de Almada CN; Nunes de Almada C; Martinez RC; Sant'Ana Ade S
    Appl Microbiol Biotechnol; 2015 May; 99(10):4175-99. PubMed ID: 25895093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The potential for probiotic manipulation of the gastrointestinal microbiome.
    Rauch M; Lynch SV
    Curr Opin Biotechnol; 2012 Apr; 23(2):192-201. PubMed ID: 22137452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.